Associate professor at School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University & Shandong Academy of Medical Sciences, China.
Dr. Xiuli Jing is an Associate Professor at the School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her research spans nanomedicine, virology, immunology, and pharmaceutical sciences ๐งช. She has contributed extensively to RNA silencing mechanisms, viral pathogenesis, and nanoparticle-based drug delivery. With numerous high-impact publications ๐, her work has advanced understanding in infectious diseases, immune response modulation, and cancer immunotherapy. She collaborates internationally, pioneering innovative treatments for major health challenges ๐.
Professional Profile:
Scopus Profile
Suitability for the Award
Dr. Xiuli Jing is highly suitable for the Best Researcher Award due to her extensive contributions to nanomedicine, virology, immunology, and pharmaceutical sciences. Her research has significantly advanced our understanding of RNA silencing mechanisms, viral pathogenesis, and nanoparticle-based drug delivery, directly impacting global health challenges such as infectious diseases, immune modulation, and cancer therapy.
Education & Experience ๐๐ฌ
โ
Ph.D. in Pharmaceutical or Biological Sciences โ (Details not provided)
โ
Associate Professor โ Shandong First Medical University & Shandong Academy of Medical Sciences (Current)
โ
Extensive Research Experience in nanotechnology, immunology, and virology
โ
Published in Prestigious Journals such as Nature Communications, Journal of Virology, and Cancer Immunology
โ
Collaborator with Leading Researchers in RNA silencing and immune regulation
Professional Development ๐๐
Dr. Xiuli Jing has consistently expanded her expertise through multidisciplinary research and international collaborations ๐. She has contributed breakthrough studies on virus-host interactions, RNA silencing, and tumor immunotherapy. Her recent work on nanoparticles’ impact on renal function has broad implications for pharmaceutical applications and disease treatment ๐. She actively mentors young scientists and participates in conferences and workshops on virology, immunology, and nanomedicine ๐ค. Her commitment to scientific advancements and translational medicine makes her a leading figure in pharmaceutical research.
Research Focus Areas ๐ฌ๐
Dr. Jing specializes in nanomedicine, virology, immunotherapy, and molecular biology. She explores RNA silencing mechanisms in viral infections ๐ฆ , focusing on avian influenza virus and herpesvirus. Her studies on immune system modulation and inflammation control have influenced cancer immunotherapy and autoimmune disease treatments ๐งฌ. Additionally, she investigates nanoparticle interactions with biological systems, enhancing drug delivery and therapeutic strategies ๐. Her multidisciplinary research integrates biotechnology, pharmacology, and medical sciences, paving the way for innovative disease treatments.
Awards & Honors ๐
๐๏ธ
๐ Recognized for High-Impact Research in Virology & Immunotherapy
๐ Recipient of Multiple Research Grants & Fellowships
๐ Published in Top-Tier Journals (Nature Communications, Journal of Virology, Allergy)
๐ Contributor to Cutting-Edge Research in Nanomedicine & RNA Silencing
๐ Active Participant in International Scientific Conferences & Collaborations
Publication Top Notes
Title: Nanoparticles Induced Glomerular Endothelial Leakiness Promoting Albuminuria Level
Authors: Yingqi Wang, Shen Zhao, Nengyi Ni, Xiao Sun, Xiuli Jing
Published in: NanoImpact, 2025